Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir Gel for High Grade Cervical Intraepithelial Lesion
NCT01303328Phase 2Completed
- Sponsor
- Mithra Pharmaceuticals SA
- Start
- Mar 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cidofovir in cervical intraepithelial neoplasia (CIN), sponsored by Mithra Pharmaceuticals SA. Started Mar 2011; status: completed.
02
Drugs
cidofovir
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT01303328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303328.